NCT00057980View on ClinicalTrials.gov

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Liver Cancer
Interventions
DRUG

celecoxib

DRUG

epirubicin hydrochloride

Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00057980 - Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter